{"id":"https://openalex.org/W2320784348","doi":"https://doi.org/10.2174/1389557515666151001154111","title":"Past, Present, and Future of Targeting Ras for Cancer Therapies","display_name":"Past, Present, and Future of Targeting Ras for Cancer Therapies","publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2320784348","doi":"https://doi.org/10.2174/1389557515666151001154111","mag":"2320784348","pmid":"https://pubmed.ncbi.nlm.nih.gov/26423695"},"language":"en","primary_location":{"id":"doi:10.2174/1389557515666151001154111","doi":"https://doi.org/10.2174/1389557515666151001154111","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389557515666151001154111","pdf_url":null,"source":{"id":"https://openalex.org/S162475533","display_name":"Mini-Reviews in Medicinal Chemistry","issn_l":"1389-5575","issn":["1389-5575","1875-5607"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mini-Reviews in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074466112","display_name":"Zhi Tan","orcid":"https://orcid.org/0000-0003-1895-0285","observed_orcids":["https://orcid.org/0000-0003-1895-0285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhi Tan","raw_affiliation_strings":[",0"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":",0","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088496837","display_name":"Shuxing Zhang","orcid":"https://orcid.org/0000-0001-8994-649X","observed_orcids":["https://orcid.org/0000-0001-8994-649X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuxing Zhang","raw_affiliation_strings":["Integrated Molecular Discovery Laboratory, Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. shuzhang@mdanderson.org","Integrated Molecular Discovery Laboratory, Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.,United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Integrated Molecular Discovery Laboratory, Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. shuzhang@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Integrated Molecular Discovery Laboratory, Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.,United States","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6353,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.61477998,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"16","issue":"5","first_page":"345","last_page":"357"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncogenic-ras","display_name":"oncogenic Ras","score":0.8240000009536743},{"id":"https://openalex.org/keywords/ras-inhibitors","display_name":"RAS inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/ras-signaling","display_name":"Ras signaling","score":0.6790000200271606},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/raf-inhibitors","display_name":"RAF inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8259999752044678},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.5087254643440247},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5069018006324768},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.49798583984375},{"id":"https://openalex.org/C127812441","wikidata":"https://www.wikidata.org/wiki/Q4774319","display_name":"Anti-apoptotic Ras signalling cascade","level":4,"score":0.493144690990448},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4439968466758728},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.44236335158348083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4164060950279236},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35506200790405273},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.35047024488449097},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.32352495193481445},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16261637210845947},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09028711915016174},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.09024214744567871}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1389557515666151001154111","doi":"https://doi.org/10.2174/1389557515666151001154111","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389557515666151001154111","pdf_url":null,"source":{"id":"https://openalex.org/S162475533","display_name":"Mini-Reviews in Medicinal Chemistry","issn_l":"1389-5575","issn":["1389-5575","1875-5607"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mini-Reviews in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:26423695","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26423695","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mini reviews in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6651570440","display_name":"Inhibition of novel molecular targets of prostaglandin formation for antitumor ac","funder_award_id":"R01CA138702","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W5640370","https://openalex.org/W154635582","https://openalex.org/W1445420130","https://openalex.org/W1483388049","https://openalex.org/W1556741602","https://openalex.org/W1558058709","https://openalex.org/W1594384581","https://openalex.org/W1597756947","https://openalex.org/W1824220821","https://openalex.org/W1971162298","https://openalex.org/W1971187774","https://openalex.org/W1989773675","https://openalex.org/W1989917629","https://openalex.org/W1992864103","https://openalex.org/W2001400574","https://openalex.org/W2009931781","https://openalex.org/W2012479646","https://openalex.org/W2023309667","https://openalex.org/W2023668202","https://openalex.org/W2024839004","https://openalex.org/W2032211985","https://openalex.org/W2033102110","https://openalex.org/W2037480365","https://openalex.org/W2037670359","https://openalex.org/W2038027636","https://openalex.org/W2042298486","https://openalex.org/W2043601243","https://openalex.org/W2044433401","https://openalex.org/W2047812331","https://openalex.org/W2057676668","https://openalex.org/W2060006898","https://openalex.org/W2061038088","https://openalex.org/W2062983115","https://openalex.org/W2066784934","https://openalex.org/W2069738597","https://openalex.org/W2073209241","https://openalex.org/W2074174599","https://openalex.org/W2074299686","https://openalex.org/W2077297619","https://openalex.org/W2087197236","https://openalex.org/W2109031404","https://openalex.org/W2112078762","https://openalex.org/W2116332105","https://openalex.org/W2121486217","https://openalex.org/W2125356859","https://openalex.org/W2128339707","https://openalex.org/W2133285965","https://openalex.org/W2135184154","https://openalex.org/W2141965353","https://openalex.org/W2144473160","https://openalex.org/W2145416541","https://openalex.org/W2148373230","https://openalex.org/W2154164444","https://openalex.org/W2156571424","https://openalex.org/W2163619954"],"related_works":["https://openalex.org/W3127981616","https://openalex.org/W3180597877","https://openalex.org/W2519500402","https://openalex.org/W2115099563","https://openalex.org/W7163584345","https://openalex.org/W2128826373","https://openalex.org/W2000297746","https://openalex.org/W4378627985","https://openalex.org/W2922251729","https://openalex.org/W2461075813"],"abstract_inverted_index":{"For":[0],"decades,":[1],"mutant":[2],"Ras":[3,29,45,67,116],"(mut-Ras)":[4],"proteins":[5],"have":[6,74],"been":[7,25,75],"identified":[8],"as":[9],"drivers":[10],"of":[11,44,72,81,92,125],"multiple":[12],"cancers":[13],"including":[14,47],"pancreatic,":[15],"lung,":[16],"and":[17,27,49,83,109],"colon":[18],"cancers.":[19],"However,":[20,56],"targeting":[21,40,95,126],"this":[22,98,107],"oncogene":[23],"has":[24],"challenging":[26],"no":[28],"inhibitors":[30],"are":[31],"on":[32,64],"the":[33,41,79,88,103,110,122],"market":[34],"to":[35,77,114],"date.":[36],"Lately":[37],"several":[38],"candidates":[39],"downstream":[42],"pathways":[43],"signaling,":[46],"PI3K":[48],"Raf,":[50],"were":[51],"approved":[52],"for":[53,90],"cancer":[54],"treatment.":[55],"they":[57],"do":[58],"not":[59],"present":[60],"promising":[61],"therapeutic":[62],"effects":[63],"patients":[65],"harboring":[66],"mutations.":[68],"Recently,":[69],"a":[70],"variety":[71],"compounds":[73],"reported":[76],"impair":[78],"activity":[80],"Ras,":[82],"these":[84],"exciting":[85],"discoveries":[86],"reignite":[87],"hope":[89],"development":[91],"novel":[93],"drugs":[94],"mut-Ras.":[96],"In":[97],"article,":[99],"we":[100,119],"will":[101,120],"review":[102],"progress":[104],"made":[105],"in":[106],"field":[108],"current":[111],"state-of-the-art":[112],"technologies":[113],"develop":[115],"inhibitors.":[117],"Also":[118],"discuss":[121],"future":[123],"direction":[124],"Ras.":[127]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}